Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oruka Therapeutics Inc ORKA

Healthcare Biotechnology
Oruka Therapeutics, Inc., formerly ARCA biopharma, Inc., is a biotechnology company. The Company is engaged in developing novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis. It is advancing a proprietary portfolio of potential antibodies that target the core mechanisms underlying plaque psoriasis and other dermatologic and inflammatory diseases. The... see more

Bullboard (NDAQ:ORKA)

View:
Post by whytestockson Aug 23, 2024 4:45pm

ARCA biopharma Announces 1-for-12 Reverse Stock Split in Con

Just In: $ABIO ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka TherapeuticsWESTMINSTER, Colo., Aug. 23, 2024 (GLOBE NEWSWIRE) -- ARCA biopharma, ...more  
34
Post by MikeTesteron Aug 02, 2024 1:22pm

ARCA biopharma, Inc. (NASDAQ:ABIO): A Precision Medicine App

https://beyondspx.com/2024/07/31/arca-biopharma-inc-nasdaqabio-a-precision-medicine-approach-to-cardiovascular-therapies-2/
23
Post by whytestockson Apr 22, 2024 11:45pm

Expected US Company Earnings on Monday, April 22nd, 2024

Just In: $ABIO Expected US Company Earnings on Monday, April 22nd, 2024Bank of Hawaii Corporation (BOH) is expected to report $0.92 for Q1 2024 Brown @ Brown Inc. (BRO) is expected to report $1.07 for ...more  
84
Post by whytestockson Apr 03, 2024 10:45am

ARCA biopharma and Oruka Therapeutics Announce Merger Agreem

JUST IN: $ABIO ARCA biopharma and Oruka Therapeutics Announce Merger AgreementMerger to create a company focused on advancing Oruka@s portfolio of novel biologics that aim to redefine the standard of ...more  
49
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities